DDO-5936
DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer[1].
Product Specifications
CAS Number
2355377-13-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ddo-5936.html
Purity
99.20
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CN(S(=O)(C1=C(C)C=C(C)C=C1C)=O)C2=CC=C(NC3=NC(N4CCCC4)=NC=C3)C=C2)O
Molecular Formula
C25H29N5O4S
Molecular Weight
495.59
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang L, et al. Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. J Med Chem. 2020;63 (3) :1281-1297.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2431-500 1x 500 µL
BAP1 (BRCA1 Associated Protein 1) (BAP1/2431), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941803-100 1x 100 µL
GP2 (Glycoprotein 2) / ZAP75 (GP2/1803), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details